Korean J Urol.  2010 Jul;51(7):483-487.

Comparative Analysis of Outcomes after Transurethral Resection of the Prostate according to Prostate Shape Shown by Transrectal Ultrasonography

• Lee HS
• Kim SJ
• Song JM
• Kim KJ
• Chung HC

Abstract

PURPOSE
Transrectal ultrasonography (TRUS) is a non-invasive modality widely used in urology on an outpatient basis to measure the volume and anatomical structure of the prostate. However, the prostate volume measured by TRUS often varies from test to test. The aim of this study was to determine the clinical significance of the different shapes of the prostate, as shown by TRUS before and after transurethral resection of the prostate (TURP).
MATERIALS AND METHODS
We evaluated 103 patients who underwent TURP. TRUS was performed preoperatively, and the International Prostatic Symptom Score (IPSS) and quality of life (QoL) were assessed preoperatively and at 6 months postoperatively. Patients were classified into two groups: patients with a bilaterally enlarged transitional zone were assigned to group A, and those with a protruding retrourethral zone were assigned to group B.
RESULTS
There were no statistically significant differences between the two groups in preoperative variables. However, postoperative IPSS scores were lower in group A than group B (9.87+/-6.15 vs. 13.18+/-8.07, p=0.02). With regard to postoperative IPSS scores relative to preoperative IPSS scores, both groups showed a significant decrease, but group A experienced a significantly greater decrease than group B (13.43+/-7.47 vs. 8.67+/-8.33, p=0.005).
CONCLUSIONS
Patients with a prostate protruding into the bladder have less of a decrease in their IPSS scores after TURP, compared to patients that do not have prostate protrusion, meaning that patients with protrusion experience less symptomatic relief.

Keyword

Prostatic hyperplasia; Transurethral resection of prostate

MeSH Terms

Humans
Outpatients
Prostate*
Prostatic Hyperplasia
Quality of Life
Transurethral Resection of Prostate
Ultrasonography*
Urinary Bladder
Urology

Figure

• 

  FIG. 1 Comparison of the two groups' preoperative and postoperative International Prostate Symptom Score (IPSS).

Reference

1. Rha KH, Choi YD, Hong SJ, Song JS, Kim BH, Choi HS, et al. Prostate volume variation with age: community-based survey in Namhae region. Korean J Androl. 2001. 19:119–124.

2. al-Rimawi M, Griffiths DJ, Boake RC, Mador DR, Johnson MA. Transrectal ultrasound versus magnetic resonance imaging in the estimation of prostatic volume. Br J Urol. 1994. 74:596–600.

3. Nunez-Nateras R, Andrews JR, Martin GL, Andrews PE, Humphreys MR, Ferrigni RG, et al. Accuracy of ultrasound in estimation of prostate weight: comparison of urologists and radiologists. Can J Urol. 2010. 17:4985–4988.

4. Wasserman NF. Benign prostatic hyperplasia: a review and ultrasound classification. Radiol Clin North Am. 2006. 44:689–710.

5. Thomas AW, Cannon A, Bartlett E, Ellis-Jones J, Abrams P. The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic followup of transurethral resection of prostate for bladder outlet obstruction. J Urol. 2005. 174:1887–1891.

6. Ignjatovic I. Prediction of unfavourable symptomatic outcome of transurethral prostatectomy in patients with the relative indication for operation. Int Urol Nephrol. 1997. 29:653–660.

7. Kuo HC, Chang SC, Hsu T. Predictive factors for successful surgical outcome of benign prostatic hypertrophy. Eur Urol. 1993. 24:12–19.

8. Lim KB, Ho H, Foo KT, Wong MY, Fook-Chong S. Comparison of intravesical prostatic protrusion, prostate volume and serum prostatic-specific antigen in the evaluation of bladder outlet obstruction. Int J Urol. 2006. 13:1509–1513.

9. Homma Y, Kawabe K, Tsukamoto T, Yamanaka H, Okada K, Okajima E, et al. Epidemiologic survey of lower urinary tract symptoms in Asia and Australia using the international prostate symptom score. Int J Urol. 1997. 4:40–46.

10. Sagnier PP, MacFarlane G, Richard F, Botto H, Teillac P, Boyle P. Results of an epidemiological survey using a modified American Urological Association symptom index for benign prostatic hyperplasia in France. J Urol. 1994. 151:1266–1270.

11. Gormley GJ, Stoner E, Bruskewitz RC, Imperato-McGinley J, Walsh PC, McConnell JD, et al. The Finasteride Study Group. The effect of finasteride in men with benign prostatic hyperplasia. N Engl J Med. 1992. 327:1185–1191.

12. Kirby RS, Bryan J, Eardley I, Christmas TJ, Liu S, Holmes SA, et al. Finasteride in the treatment of benign prostatic hyperplasia. A urodynamic evaluation. Br J Urol. 1992. 70:65–72.

13. Peters CA, Walsh PC. The effect of nafarelin acetate, a luteinizing-hormone-releasing hormone agonist, on benign prostatic hyperplasia. N Engl J Med. 1987. 317:599–604.

14. Stone NN. Flutamide in treatment of benign prostatic hypertrophy. Urology. 1989. 34:64–68.

15. Eckhardt MD, van Venrooij GE, Boon TA. Symptoms and quality of life versus age, prostate volume, and urodynamic parameters in 565 strictly selected men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Urology. 2001. 57:695–700.

16. Glynn RJ, Campion EW, Bouchard GR, Silbert JE. The development of benign prostatic hyperplasia among volunteers in the Normative Aging Study. Am J Epidemiol. 1985. 121:78–90.

17. Bruskewitz RC, Larsen EH, Madsen PO, Dorflinger T. 3-year followup of urinary symptoms after transurethral resection of the prostate. J Urol. 1986. 136:613–615.

18. Van Venrooij GE, Van Melick HH, Eckhardt MD, Boon TA. Correlations of urodynamic changes with changes in symptoms and well-being after transurethral resection of the prostate. J Urol. 2002. 168:605–609.

19. de Nunzio C, Franco G, Rocchegiani A, Iori F, Leonardo C, Laurenti C. The evolution of detrusor overactivity after watchful waiting, medical therapy and surgery in patients with bladder outlet obstruction. J Urol. 2003. 169:535–539.

20. Gormley EA, Griffiths DJ, McCracken PN, Harrison GM, McPhee MS. Effect of transurethral resection of the prostate on detrusor instability and urge incontinence in elderly males. Neurourol Urodyn. 1993. 12:445–453.

21. Seki N, Yuki K, Takei M, Yamaguchi A, Naito S. Analysis of the prognostic factors for overactive bladder symptoms following surgical treatment in patients with benign prostatic obstruction. Neurourol Urodyn. 2009. 28:197–201.

22. Nitti VW, Kim Y, Combs AJ. Voiding dysfunction following transurethral resection of the prostate: symptoms and urodynamic findings. J Urol. 1997. 157:600–603.

23. Housami F, Abrams P. Persistent detrusor overactivity after transurethral resection of the prostate. Curr Urol Rep. 2008. 9:284–290.

24. Donovan JL, Peters TJ, Neal DE, Brookes ST, Gujral S, Chacko KN, et al. A randomized trial comparing transurethral resection of the prostate, laser therapy and conservative treatment of men with symptoms associated with benign prostatic enlargement: The CLasP study. J Urol. 2000. 164:65–70.

25. Lee JM, Chung H, Kim TW, Kim HS, Wang JH, Yang SK. The correlation of intravesical prostatic protrusion with storage symptoms, as measured by transrectal ultrasound. Korean J Urol. 2008. 49:145–149.

26. Dinis P, Silva J, Ribeiro MJ, Avelino A, Reis M, Cruz F. Bladder C-fiber desensitization induces a long-lasting improvement of BPH-associated storage LUTS: a pilot study. Eur Urol. 2004. 46:88–93.

27. Mitterberger M, Pallwein L, Gradl J, Frauscher F, Neuwirt H, Leunhartsberger N, et al. Persistent detrusor overactivity after transurethral resection of the prostate is associated with reduced perfusion of the urinary bladder. BJU Int. 2007. 99:831–835.